Home › Funds › Atom Investors LP › ABT

Atom Investors LP position in ABT

ABBOTT LABORATORIES · Health Care

Atom Investors LP reported holding 50,174 shares of ABT (ABBOTT LABORATORIES) in its Q2 2026 13F filing — a position valued at US$4.6M, representing 0.41% of its reported portfolio and ranking #32 among its reported holdings. Atom Investors LP has disclosed ABT holdings in 10 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)50.17K sh
Reported value held$4.55M
Portfolio Weight0.41%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Atom Investors LP's ABT position evolved

Atom Investors LP first disclosed a stake in ABT in Q3 2023 at 26,409 shares (US$2.6M). The position peaked in Q2 2024 at 102,089 shares, worth US$10.6M. Across 10 filings, Atom Investors LP increased the stake 4 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 50,174 shares valued at US$4.6M — an increase of 29,265 shares quarter over quarter.. Notable position changes include a 65% increase in Q4 2023 (shares rose 4% over the following quarter), a 59% trim in Q1 2025 (shares rose 3% over the following quarter), a 140% increase in Q2 2026 (shares rose 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 26.41K $2.56M New
Q4 2023 43.48K $4.79M Add
Q1 2024 68.32K $7.76M Add
Q2 2024 102.09K $10.61M Add
Q3 2024 43.56K $4.97M Reduce
Q4 2024 36.22K $4.10M Reduce
Q1 2025 14.71K $1.95M Reduce
Q3 2025 2.10K $280.60K New
Q1 2026 20.91K $2.15M New
Q2 2026 50.17K $4.55M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Atom Investors LP held ABT?

Atom Investors LP has disclosed ABT holdings in 10 of the last 12 reported quarters, going back to Q3 2023.

What is Atom Investors LP's current position in ABT?

As of Q2 2026, Atom Investors LP holds 50.17K shares of ABT (ABBOTT LABORATORIES), valued at $4.55M, representing 0.41% of its reported portfolio and ranking #32.

Has Atom Investors LP been buying or selling ABT?

In the latest 13F filing (Q2 2026), Atom Investors LP increased its position in ABT. The position peaked in Q2 2024 at 102.09K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.